By blocking intrinsic downregulators of immunity, such as cytotoxic T-lymphocyte antigen 4 (CTLA-4), programmed death 1 (PD-1), and programmed death-ligand 1 (PD-L1), they disrupt the immune escape mechanism of tumor cells and significantly enhance anti-tumor immune responses. The gene discussed is CD274; the disease is neoplasm.